Sort
40,608 grants matching “prostate cancer”
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
$521,104Allen C Gao · University Of California At Davis · R01 · FY2023 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$520,926Amy E Moran · Oregon Health & Science University · R37 · FY2024 · CA
Quantitative C-arm Fluoroscopy - Prostate Brachytherapy
$520,901Everette C Burdette · Burdette Medical Systems, Inc. · R44 · FY2007 · CA
IMPROVING OUTCOMES IN PROSTATE CANCER BASED ON COMORBIDITIES: DEVELOPING PERSONALIZED MEDICINE
$520,751Vandeventer Place Research Foundation · · FY2022 · Department of the Army
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$520,680Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Maryland Prostate Cancer Case-Control Study
$520,666Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Plk1 as a prognostic biomarker for prostate cancer
$520,626Xiaoqi Liu · University Of Kentucky · R01 · FY2024 · CA
Discovery of a stem cell driving breast cancer spine metastases
$520,601Matthew Blake Greenblatt · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
$520,563William Ricke · University Of Wisconsin-Madison · R01 · FY2021 · DK
DISCOVERY OF IN VIVO CHEMICAL PROBES FOR POLYCOMB CBX DOMAINS
$520,558Stephen Vernon Frye · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
MicroRNAs in African American Prostate Cancer
$520,544Deepak Kumar · University Of The District Of Columbia · U01 · FY2015 · CA
Pax2 Interacting Proteins in Development and Disease
$520,534Gregory R Dressler · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach
$520,437Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection
$520,290Sanoj Punnen · University Of Miami School Of Medicine · R01 · FY2023 · CA
Strategies in therapeutic ultrasound for predicting in situ fields and quantifying the impact of tissue inhomogeneities
$520,277Oleg Sapozhnikov · University Of Washington · R01 · FY2021 · EB
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
$520,260Mia Hashibe · University Of Utah · R01 · FY2020 · CA
Miniaturized Real-Time Volumetric Ultrasound Imaging System
$520,235Butrus T Khuri-Yakub · Stanford University · R01 · FY2011 · CA
Ultra-Low Count Quantitative SPECT for Alpha-Particle Therapies
$520,187Abhinav K Jha · Washington University · R01 · FY2023 · EB
Utilizing genetic and functional strategies to identify causal genes and alleles
$520,107Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2015 · GM
An integrative multi-omics approach to characterize prostate cancer risk in diverse populations
$520,102Nicholas Mancuso · University Of Southern California · R01 · FY2024 · CA
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$520,078Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Intracellular Self-Assembly of Theranostic Nanoparticles for Enhanced Imaging and Tumor Therapy
$519,965Jeff W Bulte · Johns Hopkins University · R01 · FY2024 · EB
Genome-wide sequencing of prostate cancer in men of African ancestry
$519,847Christopher Alan Haiman · University Of Southern California · R01 · FY2013 · CA
South Carolina Cancer Disparities Research Center (SC CaDRe)
$519,832Judith Salley · South Carolina State University · U54 · FY2022 · CA
FDG PET-CT in Metastatic Prostate Cancer
$519,818Hossein Jadvar · University Of Southern California · R01 · FY2010 · CA